Baader Bank Aktiengesellschaft Reduces Stock Position in Docusign Inc. $DOCU

Baader Bank Aktiengesellschaft lowered its position in shares of Docusign Inc. (NASDAQ:DOCU) by 62.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,904 shares of the company’s stock after selling 12,885 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Docusign were worth $502,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Docusign by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company’s stock valued at $1,558,986,000 after buying an additional 225,525 shares during the period. State Street Corp boosted its position in Docusign by 0.5% during the 3rd quarter. State Street Corp now owns 8,116,797 shares of the company’s stock valued at $585,140,000 after buying an additional 41,821 shares during the period. Invesco Ltd. boosted its position in Docusign by 4.5% during the 3rd quarter. Invesco Ltd. now owns 2,690,121 shares of the company’s stock valued at $193,931,000 after buying an additional 116,047 shares during the period. Northern Trust Corp boosted its position in Docusign by 2.0% during the 3rd quarter. Northern Trust Corp now owns 1,994,004 shares of the company’s stock valued at $143,748,000 after buying an additional 39,140 shares during the period. Finally, Wellington Management Group LLP boosted its position in Docusign by 0.5% during the 3rd quarter. Wellington Management Group LLP now owns 1,860,347 shares of the company’s stock valued at $134,112,000 after buying an additional 9,861 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Bank of America assumed coverage on shares of Docusign in a research report on Tuesday, March 31st. They set an “underperform” rating and a $52.00 price target for the company. UBS Group dropped their price target on shares of Docusign from $75.00 to $54.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Royal Bank Of Canada dropped their price target on shares of Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a research report on Wednesday, March 18th. Robert W. Baird dropped their price target on shares of Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Finally, Morgan Stanley dropped their price target on shares of Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 18th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $61.40.

Docusign Price Performance

Shares of Docusign stock opened at $47.71 on Friday. The company has a 50-day moving average of $46.89 and a 200 day moving average of $56.22. The firm has a market cap of $9.27 billion, a price-to-earnings ratio of 32.24, a PEG ratio of 1.74 and a beta of 0.88. Docusign Inc. has a 1 year low of $40.16 and a 1 year high of $94.67.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. The business had revenue of $836.86 million for the quarter, compared to analysts’ expectations of $828.23 million. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The business’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.86 earnings per share. On average, equities analysts anticipate that Docusign Inc. will post 1.76 EPS for the current year.

Docusign announced that its Board of Directors has authorized a share buyback program on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 21% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In other Docusign news, CEO Allan C. Thygesen sold 26,250 shares of the company’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $47.78, for a total value of $1,254,225.00. Following the sale, the chief executive officer owned 152,237 shares in the company, valued at approximately $7,273,883.86. This represents a 14.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 16,696 shares of the company’s stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $48.10, for a total transaction of $803,077.60. Following the completion of the sale, the insider owned 72,458 shares in the company, valued at approximately $3,485,229.80. This trade represents a 18.73% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 64,673 shares of company stock valued at $3,077,699. Insiders own 1.01% of the company’s stock.

Docusign Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.